SAFETY AND EFFICACY OF OSIMERTINIB AS A THERAPY IN PATIENTS WITH EGFR T790M POSITIVE NON SMALL CELL LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Gadi, H. R. [1 ]
Ganta, M. R. [1 ]
Voleti, V. B. [1 ]
Rayavarapu, J. E. [1 ]
Thatavarti, R. [1 ]
机构：
[1] Excelra Knowledge Solut, Hyderabad, Andhra Pradesh, India
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.119
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN37
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [31] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [32] Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice
    Oh, Dong Kyu
    Ji, Won Jun
    Kim, Woo Sung
    Choi, Chang-Min
    Yoon, Shin-Kyo
    Rho, Jin Kyung
    Lee, Jae Cheol
    [J]. PLOS ONE, 2019, 14 (01):
  • [33] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [34] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
  • [35] Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer
    Kim, Hye Sook
    Lim, Kun Young
    Lee, Soo-Hyun
    Kim, Hyae Young
    Lee, Youngjoo
    Han, Ji-Youn
    [J]. CANCER MEDICINE, 2023, 12 (11): : 12285 - 12298
  • [36] In vivo efficacy of triplet therapy with osimertinib, cetuximab and bevacizumab for lung cancer cells harboring EGFR T790M
    Nishii, Kazuya
    Ohashi, Kadoaki
    Makimoto, Go
    Higo, Hisao
    Ninomiya, Kiichiro
    Kayatani, Hiroe
    Ninomiya, Takashi
    Kubo, Toshio
    Rai, Kammei
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Kiura, Katsuyuki
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [37] Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients
    Remon, Jordi
    Caramella, Caroline
    Joelet, Cecile
    Lacroix, Ludovic
    Lawson, Andrew
    Smalley, Sarah
    Howarth, Karen
    Gale, Davina
    Rosenfeld, Nitzan
    Green, Emma
    Plagnol, Vincent
    Planchard, David
    Bluthgen, Maria
    Gazzah, Annas
    Pannet, Chloe
    Nicotra, Claudio
    Soria, Jean-Charles
    Besse, Benjamin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1254 - S1255
  • [38] Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M
    Senoo, Satoru
    Ohashi, Kadoaki
    Nishii, Kazuya
    Hara, Naofumi
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : E140 - E142
  • [39] Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
    Yvette N. Lamb
    Lesley J. Scott
    [J]. Targeted Oncology, 2017, 12 : 555 - 562
  • [40] Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
    Lamb, Yvette N.
    Scott, Lesley J.
    [J]. TARGETED ONCOLOGY, 2017, 12 (04) : 555 - 562
12345